Researchers warn betting on clinical trials could incentivize insider trading and interfere with drug development. But Kalshi and Polymarket say they provide valuable information to patients.
(Image credit: Fred Tanneau)
admin, , TECHNOLOGY, 0
Related Articles
What does Nvidia’s meteoric rise indicate about AI’s potential?
NPR’s Ailsa Chang speaks with journalist Stephen Witt about chip-maker Nvidia’s rise to become the most valuable company in...
‘The New York Times’ takes OpenAI to court for copyright infringement
“The New York Times” and other publishers have sued OpenAI for copyright infringement, saying they did not grant the...
Microsoft turns 50: A look back at everything from the Altair to the Zune
The company helped launch the software industry and bring a computer to every desktop. Hit products like Windows and...
Tech luminaries and VCs go all-in on Kamala Harris campaign, 5 things to know
Harris started her political career in the Bay Area. And since launching her campaign, donations from Silicon Valley have...
Senate put $50 billion into chips semiconductor research
NPR’s Juana Summers speaks with Republican Sen. Todd Young of Indiana about efforts to build more computer chips in...
Why Is Facebook Launching An All-Out War On Apple’s Upcoming iPhone Update?
Facebook’s Mark Zuckerberg and Apple’s Tim Cook are fighting over iPhone privacy rules. At stake is the future of...
Rwandan Activist’s Phone Is 1 Of About 150,000 To Be Infected With Spyware
NPR’s Noel King talks to activist Carine Kanimba whose phone was infected with spyware. Her father is an imprisoned...
